Approaches to Alleviating Subcutaneous Injection-Site Pain for Citrate Formulations

The final guidance document was issued to assist bio/pharma companies in the clinical development and licensure of COVID-19 vaccines.

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?

Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.

Full Marketing Authorization has been granted for Novavax’s COVID-19 vaccine by the European Commission.

The new guidelines contain formulation recommendations for vaccines launching in autumn 2023.